for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Kitov Announces Initiation Of Phase 1/2 Clinical Trial Of NT219 In Advanced Cancer Patients

July 9 (Reuters) - Kitov Pharma Ltd:

* KITOV ANNOUNCES INITIATION OF PHASE 1/2 CLINICAL TRIAL OF NT219 IN ADVANCED CANCER PATIENTS

* KITOV PHARMA LTD - PRELIMINARY DATA FROM FIRST PART OF NT219 STUDY ANTICIPATED TO BE AVAILABLE IN SECOND HALF OF 2021 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up